Smith Nicholas Conrad bought ANRO
February 11, 2026 · Form 4 insider transaction
Smith Nicholas Conrad bought 200,000 shares of Alto Neuroscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderSmith Nicholas Conrad
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying the option shall vest on February 11, 2027, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.